Assignee
DOMPE FARM SPA
IT·24 granted patents·39 pending applications·8 citations·filing 2015–2025
Top patents by PatentIndex Score
63 records- 0189US2024358634A1Auris formulations for treating otic diseases and conditionsDOMPE FARM SPA·Filed 2024·Application pending·0 cites
- 0287US11236129B2IL-17A binding peptides and medical uses thereofDOMPE FARM SPA·Filed 2021·Granted Feb 1, 2022·2 cites·16 claims
- 0384US12285396B2Co-crystal of ketoprofen, compositions comprising the same, process of producing the same, and uses thereofDOMPE FARM SPA·Filed 2019·Granted Apr 29, 2025·2 cites·14 claims
- 0475US11918653B2Triglyceride otic formulations and uses thereofDOMPE FARM SPA·Filed 2018·Granted Mar 5, 2024·1 cites·20 claims
- 0574US2025032461A1Il-8 inihibitors for use in the treatment of some urological disordersDOMPE FARM SPA·Filed 2024·Application pending·0 cites
- 0671US12358950B2IL-17A binding peptides and medical uses thereofDOMPE FARM SPA·Filed 2021·Granted Jul 15, 2025·0 cites·10 claims
- 0771US2024398731A1C5ar inhibitors for use in the treatment of chemotherapy-induced iatrogenic painDOMPE FARM SPA·Filed 2024·Application pending·0 cites
- 0871US2026001912A1Il-17a binding peptides and medical uses thereofDOMPE FARM SPA·Filed 2025·Application pending·0 cites
- 0969US12268671B2IL-8 inhibitors for use in the treatment of chemotherapy-induced peripheral neuropathyDOMPE FARM SPA·Filed 2017·Granted Apr 8, 2025·1 cites·16 claims
- 1068US12133843B2IL-8 inhibitors for use in the treatment and/or prevention of bacterial secondary infectionsDOMPE FARM SPA·Filed 2018·Granted Nov 5, 2024·1 cites·6 claims
- 1166US11660291B2IL-8 inhibitors for use in the treatment of some sarcomasDOMPE FARM SPA·Filed 2018·Granted May 30, 2023·1 cites·19 claims
- 1266US2025009719A1Il-8 inhibitors for use in the treatment and/or prevention of bacterial secondary infectionsDOMPE FARM SPA·Filed 2024·Application pending·0 cites
- 1366US2026048030A1Reparixin liquid suspensionsDOMPE FARM SPA·Filed 2023·Application pending·0 cites
- 1464US12365644B2Co-crystal of ketoprofen, lysine and gabapentin, pharmaceutical compositions and their medical useDOMPE FARM SPA·Filed 2021·Granted Jul 22, 2025·0 cites·18 claims
- 1563US2025382333A1Method for preparing a salt of isocyclosporin aDOMPE FARM SPA·Filed 2022·Application pending·0 cites
- 1663US2023248704A1Il-8 inhibitors for use in the treatment of some sarcomasDOMPE FARM SPA·Filed 2023·Application pending·0 cites
- 1762US2024424060A1Ngf isoform for use in the treatment of ocular pathologiesDOMPE FARM SPA·Filed 2024·Application pending·0 cites
- 1861US2025177329A1Gpr120 agonists for the treatment of inflammatory bowel diseaseDOMPE FARM SPA·Filed 2023·Application pending·0 cites
- 1961US2026048006A1Intranasal administration of bdnf for the treatment of sensorineural hearing lossDOMPE FARM SPA·Filed 2023·Application pending·0 cites
- 2060US11969501B2Auris formulations for treating otic diseases and conditionsDOMPE FARM SPA·Filed 2021·Granted Apr 30, 2024·0 cites·20 claims
- 2160US10010586B2Method of treating intraocular tissue pathologies with nerve growth factorDOMPE FARM SPA·Filed 2016·Granted Jul 3, 2018·0 cites·20 claims
- 2260US2025312301A1Co-crystal of ketoprofen, compositions comprising the same, process of producing the same, and uses thereofDOMPE FARM SPA·Filed 2025·Application pending·0 cites
- 2359US12186359B2Composition containing branched-chain amino acidsDOMPE FARM SPA·Filed 2020·Granted Jan 7, 2025·0 cites·15 claims
- 2459US12102607B2C5aR inhibitors for use in the treatment of chemotherapy-induced iatrogenic painDOMPE FARM SPA·Filed 2018·Granted Oct 1, 2024·0 cites·11 claims
- 2558US12582624B2Co-crystal of gabapentin, ketoprofen and lysine, pharmaceutical compositions and their medical useDOMPE FARM SPA·Filed 2021·Granted Mar 24, 2026·0 cites·16 claims
- 2658US2025195479A1Il-8 inhibitors for use in the treatment of chemotherapy-induced peripheral neuropathyDOMPE FARM SPA·Filed 2025·Application pending·0 cites
- 2758US2026041733A1Combination for use in ophthalmologyDOMPE FARM SPA·Filed 2023·Application pending·0 cites
- 2858US2026076949A1Stable monohydrate of df2755a and process for its preparationDOMPE FARM SPA·Filed 2025·Application pending·0 cites
- 2958US2025282831A1Novel protein and nucleic acid sequences for covid-19 vaccinesDOMPE FARM SPA·Filed 2022·Application pending·0 cites
- 3058US2024180889A1Combination therapy for covid-19 vaccinationDOMPE FARM SPA·Filed 2022·Application pending·0 cites
- 3157US12150933B2IL-8 inihibitors for use in the treatment of some urological disordersDOMPE FARM SPA·Filed 2016·Granted Nov 26, 2024·0 cites·17 claims
- 3257US2024091311A1Ngf isoform for use in the treatment of ocular pathologiesDOMPE FARM SPA·Filed 2022·Application pending·0 cites
- 3357US2023226256A1New drug delivery system for ophtalmic useDOMPE FARM SPA·Filed 2021·Application pending·0 cites
- 3457US2023355713A1Peptide for therapeutic applications in the dermatological fieldDOMPE FARM SPA·Filed 2021·Application pending·0 cites
- 3556US2024066099A1Bdnf otic formulations and use thereofDOMPE FARM SPA·Filed 2021·Application pending·0 cites
- 3656US2025025435A1Co-crystals of nonsteroidal anti-inflammatory drugs, lysine and gabapentin, pharmaceutical compositions and their medical useDOMPE FARM SPA·Filed 2022·Application pending·0 cites
- 3756US2024342150A1Raloxifene for use in the treatment of sars-cov-2 variants infectionsDOMPE FARM SPA·Filed 2022·Application pending·0 cites
- 3856US2025340596A1Method for preparing a salt of isocyclosporin aDOMPE FARM SPA·Filed 2022·Application pending·0 cites
- 3955US2024180888A1C5ar1 inhibitors for treating hypersensitivity reactions to taxanesDOMPE FARM SPA·Filed 2022·Application pending·0 cites
- 4054US12528760B2Co-crystal of ketoprofen and its preparation, pharmaceutical compositions comprising the same and uses thereofDOMPE FARM SPA·Filed 2020·Granted Jan 20, 2026·0 cites·22 claims
- 4154US2024156757A1Cxcl8 inhibitor and pharmaceutical composition thereof for use in the treatment of seizuresDOMPE FARM SPA·Filed 2022·Application pending·0 cites
- 4253US12558399B2Isocyclosporin A for topical treatment of ocular diseasesDOMPE FARM SPA·Filed 2022·Granted Feb 24, 2026·0 cites·20 claims
- 4353US2026014105A1Powder mixture comprising reparixinDOMPE FARM SPA·Filed 2023·Application pending·0 cites
- 4453US2023090111A1Cxcl8 inhibitor and pharmaceutical composition thereof for use in the treatment of cancer-related fatigueDOMPE FARM SPA·Filed 2021·Application pending·0 cites
- 4553US2023390156A1Pharmaceutical packages comprising polypropylene containers and ngf aqueous formulations packaged thereinDOMPE FARM SPA·Filed 2021·Application pending·0 cites
- 4651US2023233543A1Compounds for the treatment of covid-19DOMPE FARM SPA·Filed 2021·Application pending·0 cites
- 4750US12521359B2Composition for the treatment of muscle wastingDOMPE FARM SPA·Filed 2020·Granted Jan 13, 2026·0 cites·12 claims
- 4850US2025304638A1Nerve growth factor and methods of use thereof for neurodevelopmental disabilities associated with neonatal hypoxic-ischemic encephalopathyDOMPE FARM SPA·Filed 2025·Application pending·0 cites
- 4950US2024197829A1Treatment of neuropathic corneal pain with ngfDOMPE FARM SPA·Filed 2022·Application pending·0 cites
- 5050US2023165820A1Synergistic admixtures of gabapentin and ketoprofen, pharmaceutical compositions and their medical useDOMPE FARM SPA·Filed 2021·Application pending·0 cites
Showing the top 50 of 63 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when DOMPE FARM SPA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →